期刊文献+

纳米级脂质微泡超声造影剂肿瘤被动靶向研究 被引量:2

Passive targeting study of nanoscale lipid ultrasound contrast agents on tumors
原文传递
导出
摘要 目的观察纳米微泡通过肿瘤血管内皮间隙实现被动靶向的可行性。方法20只SKOV3细胞皮下种植荷瘤裸鼠分为A组(超声显像组10只)及B组(冰冻切片组10只,再分为B1组及B2组)。制备DiI标记的纳米微泡及微米微泡并调整至相同浓度。A组:各裸鼠先后经尾静脉注射相同浓度微米微泡及纳米微泡(35μl/只,间隔1.5h),分别进行超声显像观察。B组:B1组及B2组各裸鼠分别注射相同浓度微米微泡及纳米微泡(约10μl/只),1.5h后对裸鼠进行心脏灌注后切取肿瘤组织及肌肉组织进行冰冻切片、Hoechst核染,激光共聚焦显微镜下观察不同微泡在两组织中的滞留情况。结果超声显示:纳米微泡组达峰时间及消退时间均长于微米微泡组,而峰值强度低于微米微泡组。冰冻切片观察:纳米微泡组肿瘤细胞周围见明显红色荧光聚集,微米微泡组肿瘤、肌肉组织中及纳米微泡组肌肉组织中均未见明显红色荧光。结论纳米级脂质微泡可通过肿瘤血管内皮间隙,即实现了肿瘤被动靶向。 Objective To tested the passive targeting of nanobubbles penetrating tumor vascular endothelial cells gap. Methods Twenty female BALB/c nude mice subcutaneously bearing human ovary cancer SKOV3 were devided into two groups:group A (ultrasound imaging) and group B (frozen sections: B1 and B2). DiI labled nanobubbles and microbubbles were prepared and adjusted into the same concentrations. Group A: Microbubbles and nanobubbles of 35 μl were injected into the tail vein of every mouse respectively (1.5 h interval). Ultrasound imaging were acquired. Group B: Nanobubbles and microbubbles of 10 μl were injected into the tail vein of mice in Group B1 and Group 132 respectively. Heart perfusion by PBS or 0.9% normal saline was carried out 1.5 h after bubbles injection to clear the free bubbles in blood circulation. And the tumor and muscle of right lower limb were immediately cut off for frozen slices (3μm) ,which were stained by Hoechst 33342 to mark the nucleus. Images were obtained with a confocal microscope. Results In vivo ultrasound imaging, the time to peak and clearance time of nanobubbles were longer than those of microbubbles,whereas the intensity of enhancement was lower than microbubbles. Frozen sections showed:with the confocal laser scanning microscopy imaging,quite a number of Diblabeled nanobubbles existed in the intercellular space of SKOV3 tumor, whereas there were few nanobubbles in skeletal muscle sections. In the control, rare DiI-labeled microbubbles were observed in tumors and skeletal muscle. Conclusions Self-made lipid nanobubbles were small enough to pass through the tumor vascular endothelial gap, namely achieve the tumor passive targeting.
出处 《中华超声影像学杂志》 CSCD 北大核心 2012年第11期995-999,共5页 Chinese Journal of Ultrasonography
基金 国家自然科学基金资助项目(30870717,81071167,81000191)
关键词 超声检查 微气泡 纳米技术 Ultrasonography Microbubbles Nanotechnology
  • 相关文献

参考文献4

二级参考文献30

  • 1龚秀芬.医学超声中的声学非线性研究[J].物理学进展,1996,16(3):286-298. 被引量:13
  • 2张勇,王志刚.纳米级超声造影剂的研究进展[J].临床超声医学杂志,2007,9(2):105-107. 被引量:9
  • 3龚秀芬 冯若 等.动物软组织非线性声参量B/A的研究[J].科学通报,1986,.
  • 4[4]Burns P,Powers JE, Hope Simpson D, et al. Harmonic power mode Doppler using microbubble contrast agents: an improved method for small vessel flow imaging. Proc. IEEE UFFC, 1994, 1547 - 1550
  • 5[5]Harris JR, Depoix F, Urich K. The structure of gas - filled n - butyl - 2 - cyanoacrylate (BCA) polymer pasticles. Micron, 1995,26:103- 111
  • 6[6]de Jong N. Improvements in ultrasound contrast agents. IEEE Engng Med Biol, 1996, Nov/Dec:72 - 82
  • 7[7]Burns PN. Harmonic imaging with ultrasound contrast agent. Clin Radiol, 1996,51 ( Supple 1 ): 50 - 55
  • 8[8]Frinking PJ, Bouakag A, Kirkhorn J, et al. Ultrasound contrast imag ing: current and new potential methods. Ultrasound med Biol, 2000, 26(6) :965 - 975
  • 9[9]Kim TK, Choi BI, Hah JK, et al. Hepatic tumors: contrast agent enhancement patterns with pulse - inversion harmonic US. Radiolo-gy, 2000,216:411 - 417
  • 10[10]Wilson SR, Burns PN, Muradali D, et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology, 2000,215:153 - 161

共引文献66

同被引文献30

  • 1伍星,王志刚,许川山.纳米级造影剂在超声分子显像与靶向治疗中的研究进展[J].中华超声影像学杂志,2006,15(7):539-540. 被引量:13
  • 2Li X, Liang P, Yu J, et al.Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided pereutaneous microwave ablation in patients with renal cell carcinoma [J]. Radiol Oncol,2013,47:398-404.
  • 3Sebastian S, Siedek V, Rytvina M, et al. Dynamic contrast enhanced ultrasound for differential diagnosis of submandibular gland disease [J].Eur Arch Otorhinolaryngol, 2014, 271:163 -169.
  • 4Theek B, Gremse F, Kunjachan S, et al. Characterizing EPR- mediated passive drug targeting using contrast-enhanced functional ultrasound imaging [J].J Control Release, 2014,182 83-89.
  • 5Wickline SA, Lanza GM. Nanotechnology for molecular imaging and targeted therapy[J] .Circulation, 2003,107 : 1092-1095.
  • 6Oeffinger BE,Wheatley MA.Development and characterization of a nano-scale contrast agent[J]. Ultrasonics, 2004,42 : 343-347.
  • 7Flegg MB, Poole CM, Whittaker AK, et al. Rayleigh theory of ultrasound scattering applied to liquid-flied contrast nanoparticles [J].Phy Med Biol, 2010,55 : 3061-3076.
  • 8Cheng X, Li H, Chen Y, et al. Ultrasound-triggered phase transition sensitive magnetic fluorescent nanodroplets as a multimodal imaging contrast agent in rat and mouse model[J]. PLoS One, 2013,8 :e85003.
  • 9Marsh JN, Hall CS, Scott MJ, et al. Improvements in the ultrasonic contrast of targeted perfluoroearbon nanopartielesusing an acoustic transmission line model[J].IEEE Trans Ultrason Ferroelectr Freq Control, 2002,49 : 29-38.
  • 10Matsunaga TO, Sheeran PS, Luois S, et al. Phase-change nanoparticles using highly volatile perfluoroearbons: toward a platform for extravascular ultrasound imaging[J].Theranostics, 2012,2:1185-1198.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部